59 Wareham Street, Studio #1
Boston, Massachusetts 02118
“Life is a beautiful place.” — Karen Lee Sobol
Each moment holds magic. Staying alert and daydreaming, planning ahead and improvising, these are just some of the ways my mind, heart, and energy move.
I go out to the world, roam and swim, interact and reflect. The more I look, listen, and touch, the more I see, hear, and feel. I take in my surroundings, I take mental snapshots. Then I paint. Or print, or build.
With line, form, and color, I reach into and record scenes and experiences that resonate with the familiar or the surreal, and shift our awareness of them. Working in the parallel languages of the narrative and the abstract, I engage with my subjects and connect with the energies they hold. Media and messages generate animated or serene results, sometimes weaving together.
My process is tactile and rhythmic. I rely on feedback from the look, sound, and feel of brush and paint, pen and ink, wire and cloth. I intuitively combine materials and techniques. As images and stories take shape and evolve, I engage in a creative dialogue with them. I invite you to the conversation.
Artist, author, architect, and advocate, Karen Lee Sobol is an explorer of our spiritual and physical realms. In many media, her art celebrates both nature and human nature.
As an alumna of Radcliffe College and the Harvard Graduate School of Design, Karen Lee has shown her work at both alma maters. Abroad, her work has been exhibited in Cracow, Tblisi, Amsterdam, and beyond. Her memoir—Twelve Weeks: An Artist’s Story of Cancer, Healing, and Hope—is illustrated with her art.
An affiliated artist with the School of the Museum of Fine Arts, Boston, Karen Lee expands her reach in the worlds of art and science. She serves on the executive committee of Save Venice / Boston chapter, the advisory board for the Center for Health and the Global Environment at the Harvard T.H. Chan School of Public Health, and as a goodwill ambassador for the Bing Center for Waldenstrom’s Macroglobulinemia at Dana-Farber Cancer Institute.